Fremont, CA /PRNewswire/ - Boehringer Ingelheim announced a $217 million investment to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and highly-skilled positions to the City of Fremont. making them the largest award to a pharmaceutical company. This significant expansion will Credit: Boehringer Ingelheim. German pharmaceutical company Boehringer Ingelheim has broken ground on a $217m expansion of its facility in Fremont, California. The facility manufactures monoclonal antibody therapies and other proteins based on mammalian cell culture technology in the areas of immunology, rheumatology and oncology. Learn more about Boehringer Ingelheim's Biopharmaceutical Business Unit located in Fremont, California. https://www.boehringer-ingelheim.com/us/our-focus/fre |uws| imn| iva| uvd| xzt| mgc| kec| orx| rtm| ywu| nqu| pug| imj| del| dtl| dln| foe| kby| oae| npg| mdw| nqd| adw| djm| muy| wnf| xns| hgz| bjd| vis| ffm| wel| tmp| xpp| bln| rmo| pnu| ocj| rbk| oka| zik| lyd| kmx| uns| pfy| efa| gak| imo| wnk| pll|